Recent 8-K filings for MRVI

• May 07, 2026 23:59 UTC earnings materiality 0.70 positive item 2.02item 9.01

  Maravai LifeSciences Q1 revenue up 41% to $65.8M; raises full-year guidance

  Q1 2026 revenue $65.8M, up 40.5% YoY; net loss improved to $(6.4)M from $(52.9)M.

• Feb 25, 2026 23:59 UTC earnings materiality 0.65 positive item 2.02item 9.01

  Maravai Q4 revenue $49.9M, net loss $63M; guides 2026 revenue $200-210M

  Q4 revenue $49.9M, net loss $(63.0)M, positive Adj EBITDA $0.5M (non-GAAP).

• Nov 06, 2025 23:59 UTC earnings materiality 0.75 negative item 2.02item 9.01

  Maravai Q3 revenue $41.6M, net loss $45.1M, Adj EBITDA -$10.8M

  Revenue of $41.6 million, net loss of $45.1 million, and Adjusted EBITDA loss of $10.8 million for Q3 2025.

• Oct 27, 2025 23:59 UTC leadership materiality 0.40 neutral item 5.02

  Maravai LifeSciences reduces board from 11 to 8; three directors resign

  Benjamin Daverman, Jessica Hopfield, and Murali Prahalad resigned from the Board effective Oct 21, 2025.

• Aug 11, 2025 23:59 UTC earnings materiality 0.90 negative item 2.02item 2.05item 5.02item 9.01

  Maravai Q2 revenue down 32% to $47.4M; net loss $69.8M; restructuring cuts 25% of workforce

  Q2 revenue $47.4M (-32% YoY); net loss $69.8M (incl. $30.4M goodwill impairment); adjusted EBITDA -$10.4M vs +$13.0M.

• Jul 18, 2025 23:59 UTC other_material materiality 0.65 negative item 4.01item 9.01

  Maravai LifeSciences dismisses EY, appoints Deloitte; material weakness disclosed

  EY dismissed as auditor; Deloitte appointed effective July 16, 2025 for FY 2025.

• Jun 25, 2025 23:59 UTC leadership materiality 0.55 neutral item 5.02item 7.01item 9.01

  Maravai LifeSciences appoints Rajesh Asarpota as CFO effective June 30, 2025, succeeding Kevin Herde

  Rajesh Asarpota appointed EVP and CFO effective June 30, 2025; Kevin Herde transitions to advisory role through Jan 31, 2026.

• Jun 09, 2025 23:59 UTC leadership materiality 0.65 neutral item 5.02item 7.01item 9.01

  Maravai LifeSciences appoints Bernd Brust as CEO, succeeding William Martin

  Bernd Brust named CEO and board member effective June 8, 2025; William Martin resigned as CEO and from board.

• May 28, 2025 23:59 UTC other_material materiality 0.10 neutral item 5.07

  Maravai shareholders elect 4 directors, ratify EY, approve say-on-pay at 2025 meeting

  Elected Sean Cunningham, John DeFord, Jessica Hopfield, Murali Prahalad as directors for three-year terms; each received over 88% of votes cast.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.90 · Median 0.65 · Most common event earnings

2 positive 3 negative 4 neutral

source · MRVI on sec.gov